Similar articles

• Tumor growth regulation by modulation of basic fibroblast growth factor.

  Gross JL, Herblin WF, Eidsvoog K, Horlick R, Brem SS. Gross JL, et al. EXS. 1992;61:421-7. doi: 10.1007/978-3-0348-7001-6_70. EXS. 1992. PMID: 1319779 No abstract available.
• Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.

  Auguste P, Gürsel DB, Lemière S, Reimers D, Cuevas P, Carceller F, Di Santo JP, Bikfalvi A. Auguste P, et al. Cancer Res. 2001 Feb 15;61(4):1717-26. Cancer Res. 2001. PMID: 11245488
• In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor.

  Stan AC, Nemati MN, Pietsch T, Walter GF, Dietz H. Stan AC, et al. J Neurosurg. 1995 Jun;82(6):1044-52. doi: 10.3171/jns.1995.82.6.1044. J Neurosurg. 1995. PMID: 7539064
• Models for assessment of angiogenesis in gliomas.

  Goldbrunner RH, Wagner S, Roosen K, Tonn JC. Goldbrunner RH, et al. J Neurooncol. 2000 Oct-Nov;50(1-2):53-62. doi: 10.1023/a:1006462504447. J Neurooncol. 2000. PMID: 11245281 Review.
• A dual receptor system is required for basic fibroblast growth factor activity.

  Klagsbrun M, Baird A. Klagsbrun M, et al. Cell. 1991 Oct 18;67(2):229-31. doi: 10.1016/0092-8674(91)90173-v. Cell. 1991. PMID: 1655276 Review. No abstract available.